Bluebird Bio, a biotechnology company, recently received approval from the U.S. Food and Drug Administration (FDA) for its gene therapy...
Finding the right balance between regulation and innovation in laboratory-developed tests (LDTs) is a complex and ongoing challenge in the...
The Food and Drug Administration (FDA) has recently cleared the Phase 1B Investigational New Drug (IND) application for TCB-008, a...
The Food and Drug Administration (FDA) has recently approved a Phase II study of Silmitasertib, a potential treatment for community-acquired...
The spinal fixation market has seen significant growth in recent years, driven by advancements in technology and an increasing number...
Expert Warns That FTC’s Probing Inquiries into FDA-Registered Patents Pose Detrimental Overreach In recent years, the Federal Trade Commission (FTC)...
Medtronic, a global leader in medical technology, has recently received approval from the U.S. Food and Drug Administration (FDA) for...
Valneva’s Ixchiq Receives FDA Approval as the First Vaccine for Chikungunya Virus Chikungunya virus, a mosquito-borne illness, has been a...
A Guide to Utilizing the FDA’s Best Practices for Choosing a Predicate Device When developing a new medical device, it...
Progress Made in Approving MDMA as a Treatment for PTSD Post-Traumatic Stress Disorder (PTSD) is a debilitating mental health condition...
Important Updates: Retraction Watch, Stem Cells and Metastasis, FDA Approval, and Iowa AG Lawsuit against Clinic In the ever-evolving world...
Biosyngen’s BRL03 Granted FDA Approval for Phase I/II Clinical Trials in Lung Cancer, Gastric Cancer, and Advanced Solid Tumors Biosyngen,...
Amneal Receives FDA Approval for Generic Injectable on Shortage List Amneal Pharmaceuticals, a leading generic pharmaceutical company, has recently received...
The Food and Drug Administration (FDA) has recently granted approval to Boston Scientific’s latest-generation WATCHMAN FLX ™ Pro Left Atrial...
Silk Road Medical, a leading medical device company focused on the treatment of vascular diseases, is set to present at...
